MedTrace Logo

Multi-Center Study of Sensory Stimulation to Improve Brain Function

NCT03556280 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2021-08-24

No results posted yet for this study

Summary

The Overture Study is a randomized, controlled, single-blind multi-center clinical trial using the GammaSense Stimulation system to study safety, tolerability, and efficacy in people with mild to moderate cognitive impairment.

Conditions

Interventions

DEVICE

GammaSense Stimulation System (Active Settings)

Proprietary auditory and visual sensory stimulation device.

DEVICE

GammaSense Stimulation System (Sham Settings)

Proprietary auditory and visual sensory stimulation device.

Sponsors & Collaborators

  • Cognito Therapeutics, Inc.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-24
Primary Completion
2020-08-01
Completion
2021-09-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03556280 on ClinicalTrials.gov